Anthem Biosciences Ltd

NSE: ANTHEM · BSE: 544449 · Pharmaceuticals & Biotechnology · 31 announcements

Share price: ₹890.35
Market cap: ₹50,144 Cr
Revenue (annual): ₹2,124 Cr
Net profit (annual): ₹591.8 Cr
P/E (TTM): 87.1×Sector 47.4×
Promoter holding: 71.42%-3.26% QoQ
FII holding: 2.57%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

3 Jul 2026 12:35 IST BSE

Anthem Biosciences Credit Rating

Anthem Biosciences Ltd received an ICRA rating upgrade to AA (Stable) for its facilities totaling Rs.275.5 Crore. Revised ratings cover working capital, term loan, short‑term and unallocated limits.

Value: ₹275.5 Cr

Read the filing ↗